NIKA PHARMACEUTICALS INC. (NIKA)
OQB · Healthcare · Drug Manufacturers - Specialty & Generic
$0.20
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$211.8M
Shares Outstanding
1.05B
Exchange
OQB
Currency
USD
About NIKA PHARMACEUTICALS INC.
Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -18K | -8K | -37K | -13K |
| Net Income | -18K | -8K | -37K | -13K |
| Diluted EPS | $0.00 | $0.00 | $nan | $0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -3.2M | -65K | -96K | -76K |
| Net Income | -3.2M | -65K | -96K | -76K |
| Diluted EPS | $-0.00 | $-0.00 | $0.00 | $nan |